Sonoma Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Sonoma Pharmaceuticals

08/08/2024 22:01

* Sonoma Pharmaceuticals Inc  SNOA.OQ  reported a quarterly
adjusted loss of 7 cents​​ per share for the quarter ended in
June, higher than the same quarter last year, when the company
reported EPS of -29 cents.  The lone analyst forecast for the
quarter was for a loss of 6 cents per share. 
    * Revenue fell 1.1% to $3.39 million from a year ago;
analysts
expected $3.94 million. 
    * Sonoma Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 7 cents​.
    * The company reported a quarterly loss of $1.14 million.
    * Sonoma Pharmaceuticals Inc shares had risen by 28.2% this
quarter and gained 50.8% so far this year.

FORECAST CHANGES
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "strong buy"

Wall Street's median 12-month price target for Sonoma
Pharmaceuticals Inc is $1.50 
This summary was machine generated from LSEG data August 8 at
09:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.06          -0.07          Missed
                                  -0.07          
 Dec. 31 2023      -0.21          -0.08          Beat
 Sep. 30 2023      -0.24          -0.29          Missed